EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Dasatinib and quercetin prevent alveolar bone loss in aged mice

Luisa S Battistelli, Renata M Moraes, Yuri C Santos, Jaqueline L Ribeiro iD, Maíra T Garcia, Renata F Prado, Florent Elefteriou, Ana Lia Anbinder iD

Journal of Periodontology · 2026-10 · 97 (10) · 2160-2172

DOI: 10.1002/jper.70115 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Periodontology, online erschienen am 26.03.2026. Verfasst von Luisa S Battistelli und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biosciences and Oral Diagnosis, Institute of Science and Technology, São José dos Campos, São Paulo State University (UNESP), São José …. Hauptthemen laut MEDLINE: Quercetin, Alveolar Bone Loss, Dasatinib, Aging. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Council for Scientific and Technological Development (CNPq), São Paulo Research Foundation (FAPESP), Coordination for the Improvement of Higher Education Personnel (CAPES).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Recent findings have associated alveolar bone loss (ABL) with the presence of senescent cells. Aging and the accumulation of senescent cells are associated with a pro‐inflammatory environment which may exacerbate tissue damage. Senolytics, such as dasatinib and quercetin (D&Q), eliminate senescent cells, offering potential therapeutic benefits. We evaluated the effects of D&Q on ABL during physiological aging and experimental periodontitis.

Methods

This study evaluated the effects of D&Q in two in vivo models: aging and ligature‐induced periodontitis. In the aging model, 24 male C57BL/6 mice were allocated to CTRL (control‐30 weeks of age), AGED (vehicle‐treated, euthanized after 10 months), or D&Q (monthly gavage of D&Q [5 mg/kg and 50 mg/kg] for 10 months). In the periodontitis model, 24 Wistar rats (12 weeks old) were divided into CTRL, EP (experimental periodontitis, ligature + P. gingivalis ), or D&Q (EP + weekly D&Q at 5 mg/kg and 50 mg/kg). The ABL and bone microarchitecture were assessed by microcomputed tomography and histomorphometry, and gene expression was also analyzed. The microarchitecture of the femurs was evaluated for systemic effects.

Results

In aged mice, D&Q reduced ABL, preserved the femoral cortical microarchitecture, and downregulated Il6 , Mmp13 and Lamb1 expression. In contrast, D&Q failed to prevent ABL in the periodontitis model.

Conclusion

D&Q treatment mitigated age‐related bone loss; but did not prevent EP associated bone loss under the therapeutic regimen used. These results suggest that the effects of senolytic therapy depend on disease context and treatment conditions. Plain language summary Aging increases the risk of periodontitis due to immune decline, chronic inflammation, and the accumulation of senescent cells, which release inflammatory factors that damage tissues. Senolytic drugs, such as dasatinib and quercetin (D&Q), selectively eliminate senescent cells and have shown promise in age‐related diseases. In this study, we tested whether D&Q could reduce alveolar bone loss associated with aging or experimental periodontitis. The D&Q treatment protected aged mice by reducing bone loss, but it failed to prevent bone loss in the periodontitis model. These results suggest that the benefits of senolytic therapy may depend on disease context and treatment conditions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

QuercetinAlveolar Bone LossDasatinibAgingSenotherapeuticsAnimalsMaleMiceMice, Inbred C57BLPeriodontitisDisease Models, AnimalX-Ray MicrotomographyRats, WistarCellular SenescenceRatsInterleukin-6Matrix Metalloproteinase 13

Stichwörter der Autor:innen

agingalveolar bone losscellular senescenceperiodontitis

Substanzen

QuercetinDasatinibSenotherapeuticsInterleukin-6Matrix Metalloproteinase 13

Autor:innen und Institutionen

  • Department of Biosciences and Oral Diagnosis, Institute of Science and Technology, São José dos Campos, São Paulo State University (UNESP), São José dos Campos, SP, Brazil.
  • Center for Pediatric Neurological Disease Research, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Department of Orthopedic Surgery, Baylor College of Medicine, Houston, Texas, USA.

ORCID-Profile: Jaqueline L Ribeiro, Ana Lia Anbinder

Förderung

  • National Council for Scientific and Technological Development (CNPq)
  • São Paulo Research Foundation (FAPESP)
  • Coordination for the Improvement of Higher Education Personnel (CAPES)

Zitieren

APA

Battistelli, L. S., Moraes, R. M., Santos, Y. C., Ribeiro, J. L., Garcia, M. T., Prado, R. F., Elefteriou, F., & Anbinder, A. L. (2026). Dasatinib and quercetin prevent alveolar bone loss in aged mice. Journal of Periodontology, 97(10), 2160-2172. https://doi.org/10.1002/jper.70115

Vancouver

Battistelli LS, Moraes RM, Santos YC, Ribeiro JL, Garcia MT, Prado RF, et al. Dasatinib and quercetin prevent alveolar bone loss in aged mice. Journal of Periodontology. 2026;97(10):2160-2172. doi:10.1002/jper.70115

BibTeX
@article{Battistelli2026,
  author = {Battistelli, Luisa S and Moraes, Renata M and Santos, Yuri C and Ribeiro, Jaqueline L and Garcia, Maíra T and Prado, Renata F and Elefteriou, Florent and Anbinder, Ana Lia},
  title = {Dasatinib and quercetin prevent alveolar bone loss in aged mice},
  journal = {Journal of Periodontology},
  year = {2026},
  volume = {97},
  number = {10},
  pages = {2160--2172},
  doi = {10.1002/jper.70115}
}
Kostenlos starten →